Bairen Medical: Plans to repurchase 50-100 million shares for employee ownership or incentives.

Bairen Medical announced that the company plans to repurchase shares through centralized competitive bidding trading, with an amount of not less than 50 million yuan and not more than 100 million yuan, a repurchase price not exceeding 139.05 yuan per share, and a repurchase quantity of 359,830 shares to 719,165 shares, accounting for 0.26%-0.52% of the total share capital. The repurchased shares are intended for employee stock ownership plans or equity incentives. If implementation is not completed within the specified period, the unreleased shares will be cancelled. The repurchase period is within 12 months from the date when the board of directors approved the plan. As of the announcement date, related personnel have no plans to reduce their holdings. This repurchase will not have a significant impact on the company's operations, finances, etc., but there are risks such as the inability to successfully implement the repurchase.